As expected, in our DM mice, following the reduced insulin/InsR and IGF-1/IGF-1R signaling, the SCF production by the gastric smooth muscles was clearly decreased in DM week 6, and ICC were significantly lost afterward (in DM week 8). The gene discussed is IGF1; the disease is intrahepatic cholangiocarcinoma.